[Course control of platelet function and blood lipid levels during a 2 years prospective study on the prevention of reinfarction with acetylsalicylic acid, phenprocoumon and placebo].
D015110:4-Hydroxycoumarins / Q000627:therapeutic use*; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008055:Lipids / Q000097:blood; D008137:Longitudinal Studies; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control*; D010644:Phenprocoumon / Q000627:therapeutic use*; D010919:Placebos; D010974:Platelet Aggregation / Q000187:drug effects; D012008:Recurrence
D015110:4-Hydroxycoumarins; D008055:Lipids; D010919:Placebos; D010644:Phenprocoumon; D001241:Aspirin
Verlaufskontrolle der Thrombozytenfunktion und der Blutfettwerte während einer zweijährigen prospektiven Studie zur Reinfarktprophylaxe mit Acetylsalicylsäure, Phenprocoumon oder Placebo.